EPITHELIAL OVARIAN CANCER
Clinical trials for EPITHELIAL OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new EPITHELIAL OVARIAN CANCER trials appear
Sign up with your email to follow new studies for EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weapon tested in battle against advanced ovarian cancer
Disease control OngoingThis study is testing whether adding a new experimental drug called IMNN-001 to standard chemotherapy before surgery can better control advanced ovarian, fallopian tube, or primary peritoneal cancer. The drug is designed to stimulate the immune system and is delivered directly in…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Imunon • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Heated chemo bath: a new hope for women with resistant ovarian cancer?
Disease control OngoingThis study is for women whose ovarian cancer has returned and stopped responding to standard platinum chemotherapy. It aims to see if a major surgery to remove visible tumors, followed by a heated chemotherapy solution washed directly inside the abdomen, helps patients live longe…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE3 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Early trial tests re-engineered immune cells to fight tough ovarian cancer
Disease control OngoingThis early-phase study is testing the safety of a new cell therapy for women with recurrent ovarian cancer that hasn't responded to standard treatments. Doctors modify a patient's own immune cells to recognize and attack cancer cells, then infuse them back into the abdomen. The m…
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC